Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

ZyCoV-D

Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details Here
Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details HereBhaswati Guha Majumder Nov 9, 2021 12:57 PM +05:30 IST
Closer To 100 Crore Shots: 60 Lakh Doses Of Zydus Cadilla's DNA-based Vaccine Ready For Distribution
Closer To 100 Crore Shots: 60 Lakh Doses Of Zydus Cadilla's DNA-based Vaccine Ready For DistributionBhaswati Guha Majumder Oct 14, 2021 03:38 PM +05:30 IST
First Batch Of Zydus Covid-19 Vaccine Released By Govt's Drug Laboratory For Commercial Use: Report
First Batch Of Zydus Covid-19 Vaccine Released By Govt's Drug Laboratory For Commercial Use: ReportSwarajya StaffOct 2, 2021 12:27 PM +05:30 IST
Over 5.33 Crore COVID-19 Vaccine Doses Still Available With States And UTs, 1.65 Crore More Shots In Pipeline: Centre
Over 5.33 Crore COVID-19 Vaccine Doses Still Available With States And UTs, 1.65 Crore More Shots In Pipeline: CentreSwarajya StaffSep 16, 2021 11:46 AM +05:30 IST
Over 3.29 Crore COVID Vaccine Doses Still Available With States And UTs, 1 Crore More Shots In Pipeline: Centre
Over 3.29 Crore COVID Vaccine Doses Still Available With States And UTs, 1 Crore More Shots In Pipeline: CentreSwarajya StaffAug 24, 2021 12:03 PM +05:30 IST
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: Report
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: ReportSwarajya StaffJul 7, 2021 11:42 AM +05:30 IST
10-12 Million Daily Vaccine Doses No Longer A Pipe Dream; 21 June Data Show India Can Scale Up Fast
10-12 Million Daily Vaccine Doses No Longer A Pipe Dream; 21 June Data Show India Can Scale Up FastR JagannathanJun 22, 2021 01:26 PM +05:30 IST
All You Need To Know About ZyCoV-D— Which Could Be The Next Indigenously Developed Covid-19 Vaccine To Get Approval In India
All You Need To Know About ZyCoV-D— Which Could Be The Next Indigenously Developed Covid-19 Vaccine To Get Approval In India Bhaswati Guha Majumder May 15, 2021 06:27 PM +05:30 IST
Ahmedabad Based Zydus Cadila Seeks DCGI Nod For Phase-3 Clinical Trials Of Its COVID-19 Vaccine With 30,000 Volunteers
Ahmedabad Based Zydus Cadila Seeks DCGI Nod For Phase-3 Clinical Trials Of Its COVID-19 Vaccine With 30,000 VolunteersSwarajya StaffDec 25, 2020 09:32 AM +05:30 IST
Zydus Cadila To Begin Phase-2 Clinical Trials Of 'ZyCoV-D' Covid-19 Vaccine From 6 August
Zydus Cadila To Begin Phase-2 Clinical Trials Of 'ZyCoV-D' Covid-19 Vaccine From 6 AugustSwarajya StaffAug 5, 2020 01:27 PM +05:30 IST
Human Trials Of India's First Covid-19 Vaccine Begin; 375 Volunteers To Participate In Phase-1 Trial
Human Trials Of India's First Covid-19 Vaccine Begin; 375 Volunteers To Participate In Phase-1 TrialSwarajya StaffJul 18, 2020 10:56 AM +05:30 IST
 Zydus Cadila Starts Human Clinical Trials For Its Covid-19 Vaccine Candidate ZyCoV-D
Zydus Cadila Starts Human Clinical Trials For Its Covid-19 Vaccine Candidate ZyCoV-DSwarajya StaffJul 15, 2020 11:56 AM +05:30 IST
After Bharat Biotech, Zydus Gets DCGI Nod For Human Trials Of Potential Covid-19 Vaccine
After Bharat Biotech, Zydus Gets DCGI Nod For Human Trials Of Potential Covid-19 VaccineSwarajya StaffJul 3, 2020 11:55 AM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype